Andrea F. Wainer - Dec 6, 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role: EXECUTIVE VICE PRESIDENT
Signature: /s/ Andrea F. Wainer by Jessica H. Paik, Attorney-in-Fact
Stock symbol: ABT
Transactions as of: Dec 6, 2021
Transactions value $: -$384,750
Form type: 4
Date filed: 12/8/2021, 04:29 PM
Previous filing: Nov 17, 2021
Next filing: Dec 15, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABT	Common shares without par value	Options Exercise	$212K	+4.5K	+9.04%	$47.00	54.3K	Dec 6, 2021	Direct
transaction	ABT	Common shares without par value	Sale	-$596K	-4.5K	-8.29%	$132.50	49.8K	Dec 6, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABT	Option (right to buy)	Options Exercise	$0	-4.5K	-13.54%	$0.00	28.7K	Dec 6, 2021	Common Shares	4.5K	$47.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).